From these results, we can say that tumor escape from the immune system is further facilitated by inflammatory cytokines, which are abundant in the TME of inflammation-prone tumors such as HCC, and it can be countered by using STAT1 inhibitors. The gene discussed is STAT1; the disease is hepatocellular carcinoma.